Hospira Cisplatin 1mg/mL Concentrate for Solution for Infusion 50mg/50mL vial

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

cisplatin, Quantity: 1 mg/mL

Disponible des:

Hospira Australia Pty Ltd

Designació comuna internacional (DCI):

Cisplatin

formulario farmacéutico:

Injection, intravenous infusion

Composición:

Excipient Ingredients: mannitol; sodium chloride; water for injections; hydrochloric acid; sodium hydroxide

Vía de administración:

Intravenous Infusion

Unidades en paquete:

1x 50mL pack

clase:

Medicine Listed (Export Only)

tipo de receta:

(S1) This Schedule is intentionally blank

indicaciones terapéuticas:

Cisplatin is used in the treatment of certain types of cancer, for example ovarian cancer, testicular cancer, bladder cancer and head and neck cancer. Cisplatin may be used in combination with other anti-cancer medicines.

Resumen del producto:

Visual Identification: A clear, colourless to pale yellow solution, free from visible particulates.; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estat d'Autorització:

Licence status A

Data d'autorització:

2009-02-11